Dr. Zhen Li cofounded ADARx Pharmaceuticals in 2020 and is the President and CEO of ADARx.  She has more than two decades of experience in research and development in the pharmaceutical and biotech industries.  Prior to ADARx, Dr. Li served as Senior VP at Arrowhead Pharmaceuticals where she led discovery and non-clinical development of Arrowhead’s RNA delivery platform and multiple product candidates.  Previously, Dr, Li was a director at Merck and led a team dedicated to siRNA development.  Dr. Li received her PhD in Chemistry and Chemical Biology from Harvard University and her BS from Peking University.